{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:02:25Z","timestamp":1789448545941,"version":"build-2803163510"},"reference-count":29,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["12571546"],"award-info":[{"award-number":["12571546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271786"],"award-info":[{"award-number":["82271786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"award":["12571546"],"award-info":[{"award-number":["12571546"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["82271786"],"award-info":[{"award-number":["82271786"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Science and Technology Planning Project of Guangdong Province, China","doi-asserted-by":"publisher","award":["2021B1212040017"],"award-info":[{"award-number":["2021B1212040017"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Science and Technology Program","award":["ZDSYS20230626091203007"],"award-info":[{"award-number":["ZDSYS20230626091203007"]}]},{"name":"Shenzhen Science and Technology Program","award":["202208181002233002"],"award-info":[{"award-number":["202208181002233002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Functional cure, defined as sustained hepatitis B surface antigen (HBsAg) loss, remains a major goal in chronic hepatitis B (CHB) management. HBsAg kinetics during interferon (IFN)-based therapy are associated with treatment response and prognosis, but real-world data on weekly HBsAg dynamics remain limited. This retrospective real-world study enrolled 533 CHB patients treated with IFN monotherapy or IFN plus tenofovir disoproxil fumarate (TDF), tenofovir alafenamide (TAF), or entecavir (ETV). Weekly HBsAg levels up to week 24 were analyzed using propensity score matching (PSM), subgroup analyses, and generalized estimating equations (GEEs). HBsAg kinetics showed marked heterogeneity, with some patients exhibiting transient early increases. Lower baseline HBsAg levels and rapid early decline were strongly associated with HBsAg loss. After PSM, IFN monotherapy and combination therapy showed comparable HBsAg decline trajectories. The three NA regimens demonstrated similar overall kinetics, although subgroup differences were observed by sex, immune activity, HBV DNA status, and prior treatment. TDF showed a faster decline in females, whereas ETV declined faster in males and immune-active patients. In conclusion, HBsAg kinetics during IFN-based therapy are highly heterogeneous and mainly influenced by baseline HBsAg levels, early on-treatment decline, and host factors. Weekly HBsAg monitoring may help predict treatment response and guide individualized CHB management.<\/jats:p>","DOI":"10.3390\/v18091006","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:10:23Z","timestamp":1789373423000},"page":"1006","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Weekly HBsAg Decline Dynamics During Combination Therapy with Interferon and Nucleos(t)ide Analogs: A Retrospective Real-World Study"],"prefix":"10.3390","volume":"18","author":[{"given":"Ziyuan","family":"Yi","sequence":"first","affiliation":[{"name":"School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen 518107, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Zhuoran","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen 518107, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Caixia","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518107, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Xinru","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen 518107, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Dongyang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518107, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518107, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8709-3817","authenticated-orcid":false,"given":"Kuancheng","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen 518107, China"},{"name":"Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou 514400, China"},{"name":"Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, Shenzhen Campus of Sun Yat-Sen University, Shenzhen 518107, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8184-8430","authenticated-orcid":false,"given":"Xiangjun","family":"Du","sequence":"additional","affiliation":[{"name":"School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen 518107, China"},{"name":"Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou 514400, China"},{"name":"Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, Shenzhen Campus of Sun Yat-Sen University, Shenzhen 518107, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2000-7053","authenticated-orcid":false,"given":"Caijun","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen 518107, China"},{"name":"Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou 514400, China"},{"name":"Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, Shenzhen Campus of Sun Yat-Sen University, Shenzhen 518107, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Guangyu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518107, China"},{"name":"Department of Infectious Diseases, The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu 322000, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2022). Global Health Sector Strategies on HIV, Viral Hepatitis and Sexually Transmitted Infections 2022\u20132030, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.5009\/gnl240023","article-title":"Toward a Functional Cure for Hepatitis B","volume":"18","author":"Lok","year":"2024","journal-title":"Gut Liver"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"ref_4","first-page":"769","article-title":"Guidelines for prevention and treatment of chronic hepatitis B","volume":"9","author":"Wang","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zhang, X., Yang, X., Tan, L., Tian, Y., Zhao, Z., and Ru, S. (2024). The efficacy and safety of addition of pegylated interferon to long-term nucleos(t)ide analogue therapy on functional cure of chronic hepatitis B patient: A systematic review and meta-analysis. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1474342"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2147\/IDR.S195144","article-title":"Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B","volume":"12","author":"Zheng","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.23952","article-title":"Tenofovir disoproxil fumarate (TDF), emtricitabine\/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease","volume":"53","author":"Liaw","year":"2011","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/CM9.0000000000000857","article-title":"ETV add-on peg-interferon therapy plays a positive role in reversing hepatic fibrosis in treatment-na\u00efve chronic hepatitis B patients: A prospective and randomized controlled trial","volume":"133","author":"Yang","year":"2020","journal-title":"Chin. Med. J."},{"key":"ref_9","first-page":"159","article-title":"Traditional and Novel Virologic Markers for Functional Cure and HBeAg Loss with Pegylated Interferon in Chronic Hepatitis B: A Systematic Review and Meta-analysis","volume":"14","author":"Zhang","year":"2026","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/apt.14862","article-title":"A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B","volume":"48","author":"Chan","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12985-024-02512-w","article-title":"Efficacy of short-term Peg-IFN \u03b1-2b treatment in chronic hepatitis B patients with ultra-low HBsAg levels: A retrospective cohort study","volume":"21","author":"Li","year":"2024","journal-title":"Virol. J."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kim, K.S., Iwamoto, M., Kitagawa, K., Park, H., Hayashi, S., Tsukuda, S., Matsui, T., Atsukawa, M., Matsuura, K., and Chuaypen, N. (2025). Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers. PLoS Comput. Biol., 21.","DOI":"10.1371\/journal.pcbi.1012615"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1136\/gutjnl-2024-332182","article-title":"High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy","volume":"73","author":"Fan","year":"2024","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.29213","article-title":"A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha","volume":"66","author":"Cao","year":"2017","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101723","DOI":"10.1016\/j.clinre.2021.101723","article-title":"Peginterferon alfa-2b combined with tenofovir disoproxil fumarate induced high clinical cure rate in inactive chronic hepatitis B virus carriers","volume":"45","author":"Chen","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s40121-021-00511-w","article-title":"Analysis of the efficacy and safety of pegylated interferon-\u03b12b treatment in inactive hepatitis B surface antigen carriers","volume":"10","author":"Huang","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4254\/wjh.v8.i15.637","article-title":"Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a","volume":"8","author":"Li","year":"2016","journal-title":"World J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Li, H., Lin, X., Liu, L., Qin, L., Zheng, Y., Liu, X., Wei, X., Liang, S., Liu, Y., and Zhang, J. (2022). Low level of serum immunoglobulin G is beneficial to clinical cure obtained with pegylated interferon therapy in inactive surface antigen carriers. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.864354"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yuan, Y., Deng, Z., Chen, M., Yin, D., Zheng, J., Liu, Y., Liu, X., Zou, H., Zhang, C., and Sun, C. (2021). Changes in Mental Health and Preventive Behaviors before and after COVID-19 Vaccination: A Propensity Score Matching (PSM) Study. Vaccines, 9.","DOI":"10.3390\/vaccines9091044"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2169\/internalmedicine.5432-20","article-title":"Factors associated with hepatitis B surface antigen kinetics and responses in pegylated interferon alpha-2a monotherapy for patients with chronic hepatitis B","volume":"60","author":"Itokawa","year":"2021","journal-title":"Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2009.03.006","article-title":"Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a","volume":"136","author":"Marcellin","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12072-012-9373-4","article-title":"Serum hepatitis B surface antigen kinetics in hepatitis B e antigen-negative chronic hepatitis B","volume":"7","author":"Seto","year":"2013","journal-title":"Hepatol. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4103\/0366-6999.200554","article-title":"Kinetics of hepatitis B surface antigen level in chronic hepatitis B patients who achieved hepatitis B surface antigen loss during pegylated interferon alpha-2a treatment","volume":"130","author":"Li","year":"2017","journal-title":"Chin. Med. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s12072-020-10099-x","article-title":"Effect of combination treatment based on interferon and nucleos(t)ide analogues on functional cure of chronic hepatitis B: A systematic review and meta-analysis","volume":"14","author":"Liu","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Pujantell, M., and Altfeld, M. (2022). Consequences of sex differences in type I IFN responses for the regulation of antiviral immunity. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.986840"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cgh.2023.09.002","article-title":"Sex differences in treatment response to nucleos(t)ide therapy in chronic hepatitis B: A multicenter longitudinal study","volume":"22","author":"Chau","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1021\/acs.jmedchem.6b01442","article-title":"Past, current, and future developments of therapeutic agents for treatment of chronic hepatitis B virus infection","volume":"60","author":"Pei","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/gutjnl-2016-312653","article-title":"Induction of IFN-\u03bb3 as an additional effect of nucleotide, not nucleoside, analogues: A new potential target for HBV infection","volume":"67","author":"Murata","year":"2018","journal-title":"Gut"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jvh.13724","article-title":"240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C","volume":"29","author":"Xu","year":"2022","journal-title":"J. Viral Hepat."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/9\/1006\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:11:21Z","timestamp":1789445481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/9\/1006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["v18091006"],"URL":"https:\/\/doi.org\/10.3390\/v18091006","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]}}}